<unk>  (trade name Surfaxin) is a liquid medication used to treat infant respiratory distress syndrome. It was approved for use in the United States by the U.S. Food and Drug Administration (FDA) on March 6, 2012.
Lucinactant
Oprelvekin
Trilostane
Glasdegib
Cilostazol
Conestat alfa
Ganirelix
Bergapten